Bifunctional CuSi Intermetallic Catalyst Shows Exceptional Efficiency in the Electrochemical Conversion of NO2− to NH3
Sustainable Chemistry · 10.08.2026 · 7 (3) · 44
DOI: 10.3390/suschem7030044 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sustainable Chemistry, online erschienen am 10.08.2026. Verfasst von Irina Kuznetsova und 4 weiteren Autor:innen. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.
Abstract (Originalsprache)
The ordered copper-based intermetallic compound Cu0.83Si0.17 is capable of enhancing the catalytic efficiency of the in-demand green process of the electrochemical reaction of ammonia synthesis from nitrite in comparison with a pure copper metal catalyst, which is well known and studied. The Faradaic efficiency reaches 99% with its maximum at a potential of −0.525 V (RHE), and even at low potentials (−0.1 V) it does not fall below 90%, with an NH3 yield rate of 132.3 µmol h−1 cm−2. In addition, the catalyst demonstrated high selectivity and stability.
Förderung
- Russian Science Foundation
Zitieren
APA
Kuznetsova, I., Kultin, D., Lebedeva, O., Nesterenko, S., & Kustov, L. (2026). Bifunctional CuSi Intermetallic Catalyst Shows Exceptional Efficiency in the Electrochemical Conversion of NO2− to NH3. Sustainable Chemistry, 7(3), 44. https://doi.org/10.3390/suschem7030044
Vancouver
Kuznetsova I, Kultin D, Lebedeva O, Nesterenko S, Kustov L. Bifunctional CuSi Intermetallic Catalyst Shows Exceptional Efficiency in the Electrochemical Conversion of NO2− to NH3. Sustainable Chemistry. 2026;7(3):44. doi:10.3390/suschem7030044
BibTeX
@article{Kuznetsova2026,
author = {Kuznetsova, Irina and Kultin, Dmitry and Lebedeva, Olga and Nesterenko, Sergey and Kustov, Leonid},
title = {Bifunctional CuSi Intermetallic Catalyst Shows Exceptional Efficiency in the Electrochemical Conversion of NO2− to NH3},
journal = {Sustainable Chemistry},
year = {2026},
volume = {7},
number = {3},
pages = {44},
doi = {10.3390/suschem7030044}
}
EUVIMED